Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NEO NeoGenomics Inc

0.35 (2.52%)
May 25 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 519,454
Bid Price 13.78
Ask Price 17.99
News (1)
Day High 14.33


52 Week Range


Day Low 13.90
Company Name Stock Ticker Symbol Market Type
NeoGenomics Inc NEO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.35 2.52% 14.24 00:00:06
Open Price Low Price High Price Close Price Prev Close
13.98 13.90 14.33 14.24 13.89
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,398 519,454 $ 14.22 $ 7,386,817 - 11.03 - 21.22
Last Trade Time Type Quantity Stock Price Currency
16:27:09 10 $ 14.31 USD

NeoGenomics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.82B 127.61M - 591.64M -87.97M -0.69 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NeoGenomics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NEO Message Board. Create One! See More Posts on NEO Message Board See More Message Board Posts

Historical NEO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.0415.0413.8514.58519,410-0.80-5.32%
1 Month13.9116.1213.5114.81836,3840.332.37%
3 Months15.6216.33513.3414.85755,732-1.38-8.83%
6 Months19.0421.2213.3416.11950,291-4.80-25.21%
1 Year17.6621.2211.0315.65908,991-3.42-19.37%
3 Years38.9554.746.0017.631,174,406-24.71-63.44%
5 Years21.2461.576.0023.071,042,279-7.00-32.96%

NeoGenomics Description

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.

Your Recent History

Delayed Upgrade Clock